GNT. Alzheimer (APOE)

185,40 

Identifies E2, E3, and E4 haplotypes in the Apolipoprotein E gene.

Buy
Category:

Description

SAMPLE TYPE: BLOOD

Requires venous extraction (no prior fasting necessary)

RESULTS: 20 DAYS

Delivery of results from receipt of sample

The GNT. Alzehimer identifies the ApoE genotype to evaluate the genetic influence on lipid metabolism and susceptibility to Alzheimer’s disease and cardiovascular risk. The ApoE variants (isoforms) modulate the transport of cholesterol and triglycerides and can modify the relative risk of cognitive impairment and dyslipidemia.

Its objective is to provide useful genetic information for the stratification of cognitive and cardiovascular risk and to guide prevention and lifestyle strategies.

  • Individuals with a family history of Alzheimer’s disease or other dementias.
  • Assessment of cardiovascular risk and dyslipidemia within preventive programs.
  • Patients with hypercholesterolemia or variable response to dietary changes.
  • Longevity and brain health plans in adults and seniors.

haplotypes E2, E3 and E4 in the Apolipoprotein E gene

For more information, contact the Teletest administration department at 932 12 33 45 or through the following form

Logo-Corner

Productos

RELATED

boton presupuestos boton acceso a tus pruebas boton resultados boton profesionales
boton presupuestos

BUDGETS

boton acceso a tu kit

Analysis

boton resultados

Results

boton profesionales

Professionals

imagen icono whatsapp